COST

1,028.39

-2.11%↓

81.61

+0.52%↑

144.46

+0.77%↑

189.2

+0.55%↑

PEP

150.54

+1.09%↑

COST

1,028.39

-2.11%↓

81.61

+0.52%↑

144.46

+0.77%↑

189.2

+0.55%↑

PEP

150.54

+1.09%↑

COST

1,028.39

-2.11%↓

81.61

+0.52%↑

144.46

+0.77%↑

189.2

+0.55%↑

PEP

150.54

+1.09%↑

COST

1,028.39

-2.11%↓

81.61

+0.52%↑

144.46

+0.77%↑

189.2

+0.55%↑

PEP

150.54

+1.09%↑

COST

1,028.39

-2.11%↓

81.61

+0.52%↑

144.46

+0.77%↑

189.2

+0.55%↑

PEP

150.54

+1.09%↑

Home・Aktien・Lifecore Biomedical Inc

Lifecore Biomedical Inc

Geschlossen

BrancheKonsumgüter defensiv

4.94 -0.6

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

4.8

Max

5.13

Schlüsselkennzahlen
By Trading Economics
Einkommen	-8.9M -15M
Verkäufe	-7.9M 23M
Gewinnspanne	-64.588
Angestellte	382

Empfehlungen
By TipRanks
Empfehlungen	Starkes Kaufsignal
12-Monats-Prognose	+33.94% upside

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	-102M 139M
Vorheriger Eröffnungskurs	5.54
Vorheriger Schlusskurs	4.94

Nachrichtenstimmung

By Acuity

50%

67 / 131 Ranking in Consumer defensive

Lifecore Biomedical Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Peer-Vergleich

Kursveränderung

Lifecore Biomedical Inc Prognose

Kursziel

By TipRanks

33.94% Vorteil

12-Monats-Prognose

Durchschnitt 6.67 USD 33.94%

Hoch 9 USD

Tief 5 USD

Basierend auf 4 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Lifecore Biomedical Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

4 ratings

Buy

Halten

Sell

Basierend auf 4 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Lifecore Biomedical Inc – Dist abgegeben haben.

Stimmung

By Acuity

67 / 131 Ranking in Konsumgüter defensiv

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

Über Lifecore Biomedical Inc

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States. The company engages in the manufacturing of injectable grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, such as technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.